Hello, Fool! | Login | Signup | My Fool
Oct 7, 2008 10:40 AM ET | Feedback | Site Changes | Help
A commercial-stage biopharmaceutical company dedicated to the identification, development & commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the CNS.
View All Commentary (ACOR)
Recs
evillate (< 20) Submitted: 6/02/08 11:07 AM : Start Price: $28.24 ACOR Score: 7.65
Big jump is too big. I'll watch it come down
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK